Abdul Mutlib

3.4k citations
62 papers · 2.8k · h-index 26

Impact in

  • Pharmacology top 0.2%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
    • Cholinesterase and Neurodegenerative Diseases

Papers in

    • Metabolomics and Mass Spectrometry Studies 9
    • Biochemical and Molecular Research 4
    • Pharmacogenetics and Drug Metabolism 20
    • Drug-Induced Hepatotoxicity and Protection 7

Abdul Mutlib

62 papers receiving 2.6k citations

Peers

Abdul Mutlib
Comparison fields: 5 of 134
  • Pharmacology 895
  • Pharmaceutical Science 185
  • Pharmacology 369
  • Spectroscopy 382
  • Biochemistry 118
Replace Lars Weidolf with:
Lars Weidolf Sweden
Ralph A. Stearns United States
Deborah A. Nicoll‐Griffith Canada
Donglu Zhang United States
George A. Doss United States
Wei Tang United States
Nuggehally R. Srinivas India
Nathalie Chauret Canada
Zhengyin Yan United States
Liang‐Shang Gan United States
Abdul Mutlib relative to Lars Weidolf Sweden Lars Weidolf's profile →
Citations per field
00.5×1.5×2.2×
Lars Weidolf · 1×
Citations per year

Countries citing papers authored by Abdul Mutlib

Since Specialization
Citations

This map shows the geographic impact of Abdul Mutlib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Mutlib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Mutlib more than expected).

Fields of papers citing papers by Abdul Mutlib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul Mutlib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Mutlib. The network helps show where Abdul Mutlib may publish in the future.

Co-authors

The 25 scholars most cited alongside Abdul Mutlib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abdul Mutlib Line = papers co-authored together Abdul Mutlib links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005479
2 1996229
3 2008191
4 1999120
5 2003118
6 2015114
7 2006105
8 2006101
9 200885
10 200876
11 200076
12 199574
13 200561
14 200559
15 201055
16 200750
17 200741
18 199435
19 199534
20 199933

About Abdul Mutlib

Abdul Mutlib is a scholar working on Molecular Biology, Pharmacology, Oncology, Organic Chemistry and Pharmacology, having authored 62 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (10 papers), Metabolomics and Mass Spectrometry Studies (9 papers), Analytical Chemistry and Chromatography (8 papers), Metabolism and Genetic Disorders (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), HIV/AIDS drug development and treatment (7 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Pharmacology (895 citations), Pharmaceutical Science (185 citations), Pharmacology (369 citations), Spectroscopy (382 citations) and Biochemistry (118 citations). Abdul Mutlib has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert Espina, Amit S. Kalgutkar, Joseph T. Strupczewski, Christopher L. Shaffer, Jason Boer, Kirk R. Henne, Shawn Harriman, Iain Gardner, Yasuhiro Nakai and Ernesto Callegari. Their work appears in journals such as Chemical Research in Toxicology, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry Letters and Journal of Mass Spectrometry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact